Cytek Biosciences, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2021 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cytek Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2021 to Q2 2024.
  • Cytek Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 31, 2024 was 132M shares, a 3.56% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 132M -4.85M -3.56% Jul 31, 2024 10-Q 2024-08-06
Q1 2024 131M -4.39M -3.24% Apr 30, 2024 10-Q 2024-05-08
Q3 2023 136M +696K +0.52% Oct 31, 2023 10-Q 2023-11-14
Q2 2023 136M +1.73M +1.29% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 136M +1.59M +1.19% May 5, 2023 10-Q 2023-05-09
Q3 2022 135M +88.4M +190% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 135M Aug 5, 2022 10-Q 2022-08-10
Q1 2022 134M Mar 11, 2022 10-K 2022-03-17
Q3 2021 46.4M Aug 31, 2021 10-Q 2021-09-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.